BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 28290400)

  • 1. Quetiapine-induced sleep-related eating disorder: A case report.
    Kanagasundram S
    Clin Case Rep; 2021 Jun; 9(6):e04168. PubMed ID: 34194765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleepwalking Is Associated With Coadministration of Olanzapine and Propranolol: A Case Report.
    Deng S; Hu J; Zhu X; Shang D; Wen Y; Qiu C
    J Clin Psychopharmacol; 2017 Oct; 37(5):622-623. PubMed ID: 28719423
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine-induced somnambulism.
    Kolivakis TT; Margolese HC; Beauclair L; Chouinard G
    Am J Psychiatry; 2001 Jul; 158(7):1158. PubMed ID: 11431244
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
    Gannon RL; Millan MJ
    Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine modulates the default-mode network homogeneity in recurrent drug-free schizophrenia at rest.
    Guo W; Liu F; Chen J; Wu R; Li L; Zhang Z; Chen H; Zhao J
    Aust N Z J Psychiatry; 2017 Oct; 51(10):1000-1009. PubMed ID: 28605934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine-Related Somnambulism: A Systematic Review of Literature and a Case Report of Anorexia Nervosa.
    de Filippis R; Guinart D; Rania M; Carbone EA; Gaetano R; Segura-Garcia C
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):658-666. PubMed ID: 34668875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 5HT1A and 5HT2A receptors and default mode network in olanzapine-induced somnambulism.
    Das S; Gupta R; Dhyani M; Sah D; Maity J
    Neurol India; 2017; 65(2):373-374. PubMed ID: 28290400
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
    Stahl SM; Shayegan DK
    J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 5-HT2A receptors in antipsychotic activity.
    Schmidt CJ; Sorensen SM; Kehne JH; Carr AA; Palfreyman MG
    Life Sci; 1995; 56(25):2209-22. PubMed ID: 7791509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switch-associated adverse events: focus on olanzapine.
    Xu L; Krishnaswamy S
    Australas Psychiatry; 2018 Dec; 26(6):635-639. PubMed ID: 30407073
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.